Oslo Cancer Cluster is an oncology research and industry cluster dedicated to improving the lives of cancer patients by accelerating the development of new cancer diagnostics and treatment.
Oslo Cacner Cluster is a national non-profit member organization with about 90 members in 2018. The members are Norwegian and international companies, research and financial institutions, university hospitals and organizations – all working in the cancer field. They represent the entire oncology value chain, doing everything from exploratory research to selling therapeutics and diagnostics to global markets.
In 2007, Oslo Cancer Cluster became a Norwegian Centre of Expertise. Since then, the cluster has developed into a strong biotech cluster well positioned in the global oncology industry. The world class research environment in immunotherapy and the presence of IT-companies, strengthen the cluster’s position as a global knowledge and innovation centre in the cancer field.
Read more: oslocancercluster.no